UL Solutions Director Marla Gottschalk Receives Award

What Happened
Marla C. Gottschalk, a director of UL Solutions Inc. (ULS), received three grants on Sept 10, 2026 totaling 19 deferred restricted stock units (DRSUs) — 10, 5 and 4 units respectively. Each grant was recorded at $0.00 (award/derivative transaction code A), meaning no cash was paid. Each DRSU represents a contingent right to one share of UL Solutions Class A common stock and includes accrued dividend-equivalent rights.

Key Details

• Transaction date: 2026-09-10; reported on Form 4 filed 2026-09-14 (4 days after the grant). The filing appears later than the typical 2-business-day SEC filing window.
• Price: $0.00 per unit (award). Total cash value at grant: $0.00 recorded.
• Total units granted: 19 DRSUs (10 + 5 + 4). These are derivative awards convertible to shares per the Plan.
• Shares owned after transaction: not specified in this report.
• Notable footnotes:
  • F1 — Each DRSU equals a contingent right to one share.
  • F2/F3/F5/F6 — Dividend-equivalent rights accrue on the DRSUs and vest proportionately with the underlying DRSUs; some DRSUs already vested (e.g., May 1, 2025 and May 20, 2026), while other DRSUs vest later (e.g., by May 20, 2027 or at the next annual meeting).
  • Settlement: vested DRSUs will be settled in shares on a date selected by the reporting person under the Non-Employee Director Deferred Compensation Plan or as provided by the Plan.

Context
DRSUs are compensation awards for directors that convert to shares (or are settled in shares) at vesting or upon the director’s selected settlement date. Because these are grants (not purchases or sales), they don't indicate an immediate buy/sell sentiment; they reflect routine director compensation. The late reporting (filed four days after the grants) is notable since Section 16 filers generally must report insider transactions within two business days.